Literature DB >> 16339325

Aged rat myocardium exhibits normal adenosine receptor-mediated bradycardia and coronary vasodilation but increased adenosine agonist-mediated cardioprotection.

Gentian Kristo1, Yukihiro Yoshimura, Byron J Keith, Robert M Mentzer, Robert D Lasley.   

Abstract

The purpose of this study was to determine whether aged myocardium exhibits decreased responsiveness to adenosine A1 and A(2a) receptor activation. Studies were conducted in adult (4-6 months) and aged (24-26 months) Fischer 344 x Brown Norway hybrid (F344 x BN) rats. Effects of the adenosine A1/A(2a) agonist AMP579 were measured in isolated hearts and in rats submitted to in vivo regional myocardial ischemia. Aged isolated hearts exhibited lower spontaneous heart rates and higher coronary resistance, as well as normal A1- and A(2a)-mediated responses. There was no difference in control infarct size between adult and aged rats; however, AMP579 treatment resulted in a 50% greater infarct size reduction in aged rats (18 +/- 4% of risk area) compared to adult rats (37 +/- 3%). These findings suggest that adenosine A1 and A(2a) receptor-mediated effects are not diminished in normal aged myocardium, and that aged hearts exhibit increased adenosine agonist-induced infarct reduction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16339325     DOI: 10.1093/gerona/60.11.1399

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  3 in total

Review 1.  Adenosine receptors and reperfusion injury of the heart.

Authors:  John P Headrick; Robert D Lasley
Journal:  Handb Exp Pharmacol       Date:  2009

2.  Effects of isoflurane on coronary blood flow velocity in young, old and ApoE(-/-) mice measured by Doppler ultrasound.

Authors:  Craig J Hartley; Anilkumar K Reddy; Sridhar Madala; Lloyd H Michael; Mark L Entman; George E Taffet
Journal:  Ultrasound Med Biol       Date:  2007-04       Impact factor: 2.998

3.  Adenosine Receptor-Mediated Cardioprotection-Current Limitations and Future Directions.

Authors:  Robert D Lasley
Journal:  Front Pharmacol       Date:  2018-04-04       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.